NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.
Mã chứng khoánNPCE
Tên công tyNeuropace Inc
Ngày IPOApr 22, 2021
Giám đốc điều hànhMr. Joel D. Becker
Số lượng nhân viên184
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhApr 22
Địa chỉ455 N. Bernardo Avenue
Thành phốMOUNTAIN VIEW
Sàn giao dịch chứng khoánNASDAQ Global Market Consolidated
Quốc giaUnited States of America
Mã bưu điện94043
Điện thoại16502372700
Trang webhttps://www.neuropace.com/
Mã chứng khoánNPCE
Ngày IPOApr 22, 2021
Giám đốc điều hànhMr. Joel D. Becker
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu